Drug
Ibandronic acid
Ibandronic acid is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
67%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
2(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (100.0%)
Trials by Status
completed267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_2
Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors
NCT02616744
completed
Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis
NCT02271204
unknownphase_2
Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients
NCT00381368
Clinical Trials (3)
Showing 3 of 3 trials
NCT02616744Phase 2
Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors
NCT02271204
Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis
NCT00381368Phase 2
Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3